Immunotherapy: PD-1-PD-L1 axis: efficient checkpoint blockade against cancer
- PMID: 25533942
- DOI: 10.1038/nrclinonc.2014.221
Immunotherapy: PD-1-PD-L1 axis: efficient checkpoint blockade against cancer
Comment on
-
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer.Nature. 2014 Nov 27;515(7528):558-62. doi: 10.1038/nature13904. Nature. 2014. PMID: 25428503 Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials